USPTO serial 86444513
Serial No. 86444513
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 1, 2015
- Examiner
- VAGHANI, MAYUR C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with Serial No. 86444513?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maren C. Perry
Maren C. Perry King & Spalding LLP1290 Avenue of the AmericasNew York, NY 10104United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Vaccines; ] pharmaceutical preparations and substances for the [ prevention and ] treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; [ central nervous system stimulants; ] pharmaceutical preparations and substances for the [ prevention and ] treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of [ Alzheimer's disease and disorder, stroke, ] depression, mood disorders, psychosis and anxiety [, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, oncology, pain, alcoholism and dependency; medical diagnostic preparations for medical purposes, reagents for medical use, diagnostic agents preparations and substances for medical purposes ] | ACTIVE | — |
| 041 | [ Education services, namely, providing continuing medical education courses; providing of training, namely, medical training and teaching; arranging and conducting educational seminars, conferences, symposiums, workshops, training and courses in the field of medicine; educational classes, courses, seminars and workshops and training services in the field of research and development for the treatment and prevention of brain and central nervous system diseases and disorders, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention; educational services, namely, seminars, conferences, symposiums, workshops, training and courses and training services in the field of medical research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease provided electronically, on-line, via the Internet and global communications networks; education services, namely, arranging and conducting of expert forums, in the form of seminars, conferences, symposia, workshops and courses in the field of medicine; educational services, namely, providing medical training online; ] providing non-downloadable, on-line publications, namely, [books, ] reports, brochures, booklets, leaflets, including patient information leaflets, [ magazines, journals, teaching and educational material in the nature of articles, journals ] in the field of medical research and development, science, clinical tests and trials, medical diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease | ACTIVE | — |
| 042 | [ Scientific and technological services, namely, scientific research in the field of medicine; industrial analysis in the nature of research services in the field of pharmaceuticals; providing online non-downloadable software in the field of research and development for use in database management in the field of the treatment and prevention of brain and central nervous system diseases and disorder and an online searchable database in the field of research and development, science, clinical tests and trials, diagnostic, medicine, pharmaceuticals, disorders, diseases, treatment and prevention for the purpose of scientific research; providing a secured-access website that gives registered medical experts the ability to upload, view, download, and share documents and images for the purposes of research and development in the field of clinical tests and trials, science, patient diagnostics, medicine, pharmaceuticals, disorders, diseases, treatment and prevention of disease; pharmaceutical research and development; scientific and technological services, namely, research in the field of medical disorders, diseases and prevention of disease; scientific and technological services, namely, scientific research in the field of the treatment and prevention of brain and central nervous system related disorders, diseases and pharmaceuticals; medical research, conducting clinical medical trials and testing in the field of pharmaceuticals for others; medical services, namely, medical research; medical diagnostic research and tests, namely, clinical trials for others; ] providing medical research information in the field of pharmaceutical research and development, clinical tests and trials | ACTIVE | — |
| 044 | Medical services in the field of psychiatry and psychology, namely, medical advice related to medical and pharmaceutical preparations and substances; [ medical clinical services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; medical treatment services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; therapeutic treatment services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; therapeutic clinical services in the field of the treatment and prevention of brain and central nervous system diseases and disorders; ]healthcare and medical services related to central nervous system and brain disorders, diseases and pharmaceuticals; providing information relating to [ diagnostic and ] therapeutic properties of pharmaceuticals in the field of disorders, diseases, treatment and prevention; providing medical information services; providing on-line medical data and analyses designed to provide patients and clients customized information, including medical dose, diagnosis, therapeutic issues and medical management | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by H. Lundbeck A/S
- Other trademarks owned by H. Lundbeck A/S
- Other trademarks owned by H. Lundbeck A/S
- Other trademarks in Class 005
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 26, 2026 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Feb 26, 2026 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Feb 26, 2026 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Feb 23, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 26, 2025 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Dec 1, 2024 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Mar 22, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 22, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 22, 2024 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Mar 22, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 22, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 20, 2023 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Mar 20, 2023 | 8.OK | REGISTERED - SEC. 8 (6-YR) ACCEPTED | The USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline. |
| Jan 20, 2023 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Jul 20, 2022 | PRA8 | POST REGISTRATION ACTION MAILED - SEC. 8 | — |
| Jun 8, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 7, 2022 | XXXX | POST REGISTRATION ACTION CORRECTION | — |
| May 7, 2022 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| May 7, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 30, 2021 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Dec 1, 2020 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 28, 2015 | PRA7 | REGISTERED - SEC. 7 REQUEST ABANDONED | — |
| Dec 28, 2015 | CORV | REVIEW OF CORRESPONDENCE COMPLETE - CERTIFICATE OF REG MAILED | — |
| Dec 28, 2015 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 10, 2015 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Dec 1, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 15, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 15, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 26, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 11, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 6, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 6, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 6, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 29, 2015 | ALIE | ASSIGNED TO LIE | — |
| Jul 21, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 10, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 15, 2014 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Nov 14, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 7, 2014 | NWAP | NEW APPLICATION ENTERED | — |